Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
LipiGesic H is an over-the-counter, nonprescription headache treatment product developed by PuraMed BioScience as part of its LipiGesic line, positioned specifically for the relief of tension-type headaches. While detailed public composition data are not available, it is described by the developer as an herbal-based formulation analogous to LipiGesic M, which combines botanical ingredients in a fast-acting delivery system. The product is intended to provide symptomatic relief of muscle tension and pain associated with tension headaches through multimodal actions on inflammatory, vascular, and nociceptive pathways typical of herbal analgesic therapies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on LipiGesic H.